The BioCentury 100 declined 14% from its all-time high on February 27, but still ended higher than the general indices. Excluding partnership monies, $19 billion was raised—the highest amount since 4Q11. Private companies raised $1.9 billion. Thirty-six companies raised $2.6 billion going public, with 95 firms raising $6.5 billion over the past 15 months). Demand for follow-on financings and private investments in public equity (PIPEs) was also up. Debt financings totaled $8 billion, led by a $4-billion note by Gilead (Foster City, CA, USA).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yang, W. 1Q14—Companies flush, investors snatch profits. Nat Biotechnol 32, 410 (2014). https://doi.org/10.1038/nbt.2904
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2904
